• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.03% Nasdaq Up1.29%

    More On PRL.MI

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Pierrel S.p.A. (PRL.MI)

    -Milan
    0.91 Down 0.03(3.10%) Apr 30, 11:25AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Pierrel S.p.A.
    s.s. Appia 7 bis 46/48
    Capua, MI 81043
    Italy - Map
    Website: http://www.pierrel.it

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    Pierrel S.p.A. provides contract research and manufacturing services to the pharmaceutical and life science industries. The company is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations. It also provides consulting and operational services for the research and development of new molecules and drug products; and consulting services for clinical and regulatory development programs, as well as operational services for the execution of international phase I-IV, late phase, and non-interventional clinical trials. Pierrel S.p.A. has an agreement with Tixupharma for the development and sale of a device to treat periodontitis patients. The company operates in the United States, Australia, Canada, Russia, and the Middle East. Pierrel S.p.A. is based in Capua, Italy.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Pierrel S.p.A.

    Key Executives 
     PayExercised
    Mr. Fulvio Citaredo , 53
    Chief Exec. Officer, Gen. Mang. and Exec. Director
    N/AN/A
    Dr. Henri Kool van Langenberghe Ph.D., 59
    Chief Operating Officer
    N/AN/A
    Dr. Maria Teresa Ciccone , 37
    Accounting Mang.
    N/AN/A
    Mr. Toni Valente , 54
    Technical Director
    N/AN/A
    Dr. Stephan Henauer M.D., 64
    Chief Scientific Officer
    N/AN/A
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.